Cardiff Lexingtn Corp

Good morning everyone and thank you for participating in today's conference call to discuss Cardiff Lexingtn's financial results for the second quarter ended June 30th, 2026. At this time all participants are on a listen-only mode and a question and answer session will follow the formal presentation. If anyone should require operator assistance during the conference, please press star zero on your telephone keypad. And as a reminder, this conference call is being recorded. I would now like to turn the call over to Mr. Walter Frank of IMS Investor Relations. Sir, please go ahead.

Thank you, operator. I would like to welcome everybody to the call. Hosting the call today are Carter Lexington's CEO, Alex Cunningham, and CFO, Matt Shafer. I would like to take a moment to read the Safe Harbor Statement. This conference call contains forward-looking statements as defined within Section 27A of the Securities Act of 1933 as amended and Section 21E of the Securities Exchange Act of 1934 as amended. These forward-looking statements and terms such as anticipate, expect, intend, may, will, should, or other comparable terms involve risks and uncertainties because they relate to events and depend on circumstances that will occur in the future. Those statements include statements regarding the intent, belief, or current expectations of Cardiff Lexington and members of its management, as well as the assumptions on which such statements are based. Prospective investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, including those described in Cardiff Lexington's periodic reports filed with the SEC, and that actual results may differ materially from those contemplated by such forward-looking statements. except as required by federal securities law, Carter-Flexington undertakes no obligation to update or revise forward-looking statements to reflect change conditions. I would now like to turn the call over to the CEO of Carter-Flexington, Alex Cunningham.

Thanks, Walter. Good morning and thank you for joining our conference call today to discuss our second quarter 2026 results. I will start by providing an overview of our performance and strategy which will focus more on year-to-date progress before turning the call over to Matt Shafer, our Chief Financial Officer, for a deeper dive into our financial results in the second quarter. We will then open the call for a brief Q&A. The first half of 2026 is summarized by continued execution of our long-term strategy to establish Nova Ortho and Spine as a leading healthcare network and provide best in class care to a severely underserved patient population. On the operational front, we announced our 12th Nova Ortho and Spine location with the addition of privileges at Southeastern Surgery Center in Tallahassee, Florida. As the capital city of Florida, Tallahassee represents a strategic metropolitan location with high patient volume and visibility that aligns perfectly with our long-term growth strategy and enhances our ability to provide leading medical care. We also announced a new location in Stewart, Florida, which allows us to tap into the healthy demand that we're seeing from Florida's Treasure Coast, which maintains one of Florida's highest concentrations of residents age 55 and older. a demographic frequently requiring orthopedic, spine, pain management, and mobility related healthcare services. We also continue to strengthen our team of leading doctors, nurses, and healthcare operators who are the backbone of the services we provide. While we executed well, the first half of the year was not without its challenges. Revenue decreased from last year, primarily related to fewer billed surgical procedures, as well as lower implicit realization rates on patient case claim settlements. Despite this, our gross margins remained healthy at 57% for the year to date, and our non-GAAP adjusted EBITDA was a relatively small loss reflecting the resilience of our business model. Demand is very strong and we are in a very attractive market. That said, working capital constraints have impacted our ability to go out and take advantage of the many opportunities that we're seeing in the market. A top priority remains reducing our cost of capital to support our growth. We are well positioned with strong brand recognition in the markets that we currently serve and we're committed to the continued execution of our long-term strategy, providing the best care available to our patients across our expanding network of Nova Ortho and Spine locations. With that, I'll now hand the call over to our Chief Financial Officer, Matt Shafer, to take a deeper dive into our financial results for the second quarter. Matt?